Cheever MA - Search Results

1

Induction of multiple anti-c-erbB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatment.

Clark JI, Alpaugh RK, von Mehren M, Schultz J, Gralow JR, Cheever MA, Ring DB, Weiner LM. Clark JI, et al. Among authors: cheever ma. Cancer Immunol Immunother. 1997 Jul;44(5):265-72. doi: 10.1007/s002620050382. Cancer Immunol Immunother. 1997. PMID: 9247561 Free PMC article. Clinical Trial.

2

Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-protein.

Disis ML, Gralow JR, Bernhard H, Hand SL, Rubin WD, Cheever MA. Disis ML, et al. Among authors: cheever ma. J Immunol. 1996 May 1;156(9):3151-8. J Immunol. 1996. PMID: 8617935

3

High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer.

Disis ML, Pupa SM, Gralow JR, Dittadi R, Menard S, Cheever MA. Disis ML, et al. Among authors: cheever ma. J Clin Oncol. 1997 Nov;15(11):3363-7. doi: 10.1200/JCO.1997.15.11.3363. J Clin Oncol. 1997. PMID: 9363867

4

Immunity to the HER-2/neu oncogenic protein.

Disis ML, Bernhard H, Gralow JR, Hand SL, Emery SR, Calenoff E, Cheever MA. Disis ML, et al. Among authors: cheever ma. Ciba Found Symp. 1994;187:198-207; discussion 207-11. doi: 10.1002/9780470514672.ch13. Ciba Found Symp. 1994. PMID: 7540970 Review.

5

Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.

Bernhard H, Disis ML, Heimfeld S, Hand S, Gralow JR, Cheever MA. Bernhard H, et al. Among authors: cheever ma. Cancer Res. 1995 Mar 1;55(5):1099-104. Cancer Res. 1995. PMID: 7532543

6

Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines.

Disis ML, Bernhard H, Shiota FM, Hand SL, Gralow JR, Huseby ES, Gillis S, Cheever MA. Disis ML, et al. Among authors: cheever ma. Blood. 1996 Jul 1;88(1):202-10. Blood. 1996. PMID: 8704175 Free article.

7

Translational Research Working Group developmental pathway for immune response modifiers.

Cheever MA, Schlom J, Weiner LM, Lyerly HK, Disis ML, Greenwood A, Grad O, Nelson WG; Translational Research Working Group. Cheever MA, et al. Clin Cancer Res. 2008 Sep 15;14(18):5692-9. doi: 10.1158/1078-0432.CCR-08-1266. Clin Cancer Res. 2008. PMID: 18794077 Free PMC article.

8

Immunity to oncogenic proteins.

Cheever MA, Disis ML, Bernhard H, Gralow JR, Hand SL, Huseby ES, Qin HL, Takahashi M, Chen W. Cheever MA, et al. Immunol Rev. 1995 Jun;145:33-59. doi: 10.1111/j.1600-065x.1995.tb00076.x. Immunol Rev. 1995. PMID: 7590829 Review. No abstract available.

9

The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research.

Cheever MA, Allison JP, Ferris AS, Finn OJ, Hastings BM, Hecht TT, Mellman I, Prindiville SA, Viner JL, Weiner LM, Matrisian LM. Cheever MA, et al. Clin Cancer Res. 2009 Sep 1;15(17):5323-37. doi: 10.1158/1078-0432.CCR-09-0737. Clin Cancer Res. 2009. PMID: 19723653 Free PMC article.

10

Dendritic cells lose ability to present protein antigen after stimulating antigen-specific T cell responses, despite upregulation of MHC class II expression.

Bernhard H, Huseby ES, Hand SL, Lohmann M, Batten WY, Disis ML, Gralow JR, Meyer zum Büschenfelde KH, Ohlén C, Cheever MA. Bernhard H, et al. Among authors: cheever ma. Immunobiology. 2000 Apr;201(5):568-82. doi: 10.1016/s0171-2985(00)80075-3. Immunobiology. 2000. PMID: 10834314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters